FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1074651000202105: Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Feb 2024. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
11777831000202113 Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
11793691000202113 Linagliptin 2.5 mg and metformin hydrochloride 850 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Is a Product containing only linagliptin and metformin in oral dose form (medicinal product form) true Inferred relationship Some
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form Oral tablet true Inferred relationship Some
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Metformin hydrochloride true Inferred relationship Some 1
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Metformin hydrochloride true Inferred relationship Some 1
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 1
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Linagliptin (substance) true Inferred relationship Some 2
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Linagliptin (substance) true Inferred relationship Some 2
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 2
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

GB English

US English

Back to Start